DealFlowAgent

    Buy-Side Advisory · UK & US

    Buy a medical aesthetics & medispas business.

    Curated, pre-qualified deal flow for buyers acquiring medical aesthetics & medispas businesses across the UK and US.

    £500K–£50M

    Enterprise Value

    UK & US

    Coverage

    Free

    For Acquirers

    Sterling

    Share Your Acquisition Criteria

    Get matched with curated, pre-qualified businesses in your target sectors. Takes 2 minutes.

    Free. Confidential. No spam.

    Sector Thesis

    Why buyers are acquiring medical aesthetics & medispas businesses

    Strong consumer demand

    Aesthetic treatment demand has grown materially across both UK and US markets, with younger demographics now contributing.

    Recurring repeat-treatment model

    Most aesthetic treatments involve scheduled top-ups, supporting recurring revenue.

    Multi-site platform potential

    Strong unit economics support multi-site platform creation by capable operators.

    Coverage

    Medispa & Medical Aesthetics Businesse sub-niches we cover

    Injectables Clinics

    Botox, filler and anti-wrinkle treatment clinics.

    Laser & Energy-Based

    Laser, IPL and energy-based aesthetic clinics.

    Skin & Dermatology

    Medical-grade skin and dermatology clinics.

    Cosmetic Surgery Clinics

    Surgical cosmetic clinics with theatre.

    Deal Sizes & Multiples

    What medical aesthetics & medispas businesses actually trade for

    Medispa valuations reward clinician retention, recurring patient bookings, marketing efficiency, regulatory standing and any multi-site platform structure.

    Mandates we surface generally sit between £500K and £50M in enterprise value, with most opportunities concentrated in the £1M–£20M range.

    Diligence

    Due diligence focus areas for medical aesthetics & medispas acquisitions

    The diligence themes most likely to move price, deal structure or completion certainty.

    Regulatory standing

    Verify CQC / state-board registration where applicable, especially for surgical and prescribing settings.

    Clinician dependency

    Revenue often concentrates with one or two practitioners — verify retention plans and restrictive covenants.

    Marketing dependency

    Paid marketing dependency can mask weak retention — analyse organic vs. paid acquisition mix.

    Insurance and complaints history

    Cosmetic claims and complaints carry reputational risk — review claims history.

    Announcement · $750,000 raised

    Backed by investors behind Uber, SpaceX, Canva, Notion and others, to modernise M&A advisory for business owners and buyers like you.

    We have raised investment from the same backers behind companies that transformed entire industries.

    Capital is being deployed to keep delivering successful exits — sharper buyer mapping, a stronger advisory bench, and a faster process for owners.

    Uber logo
    SpaceX logo
    Canva logo
    Notion logo
    Loom logo
    DeepMind logo
    Together.ai logo
    Crusoe logo
    Carta logo
    Recent press coverage of DealFlowAgent's $750k funding round across The Next Web, EU-Startups, Startup Researcher, Startupmag and X, alongside new partnerships with Tradeaze and Simpro.
    Recent press coverage and new partnerships.
    Featured inTNWEU-Startups
    Related Sectors

    Other buyside opportunities

    Owner of a medical aesthetics & medispas business?

    Considering a sale of your medical aesthetics & medispas business?

    DealFlowAgent runs the deal flow engine that connects medical aesthetics & medispas owners with credible acquirers across the UK and US.

    See our sell-side service
    FAQ

    Buying a medical aesthetics & medispas business — your questions answered

    What size medical aesthetics & medispas businesses does Sterling source?
    Sterling sources medical aesthetics & medispas businesses generally between £500K and £50M in enterprise value, with most opportunities concentrated in the £1M–£20M range across the UK and US.
    Are medical aesthetics & medispas mandates exclusive to DealFlowAgent?
    Mandates come from a mix of direct owner introductions and partner sell-side advisors. Process exclusivity is confirmed with each owner or advisor before any introduction is made.
    Can Sterling source bolt-on medical aesthetics & medispas targets for a platform?
    Yes. Many of our buyers are platforms looking for geographic or service-line bolt-ons. Sterling learns your specific add-on thesis and surfaces matches as they appear in the network.
    How long until a first medical aesthetics & medispas introduction?
    Timing depends on the specificity of your criteria and current mandate availability. Sterling shares matches as soon as suitable opportunities surface in the network.